In the first large randomized trial to directly compare two approaches to preventing atrial fibrillation following heart surgery, controlling heart rate and controlling heart rhythm performed equally well.

TAVR, Sapien 3, ACC.16

The continuation of positive clinical trial data for transcatheter aortic valve repair (TAVR), showing it is equal to or better than surgical aortic valve replacement (SAVR) was the key news from the American College of Cardiology (ACC) 2016 meeting in April. The continued positive news also made many experts at ACC begin to question the long-term future of SAVR.

In one of the largest trials ever conducted of heart failure patients with reduced ejection fraction, the investigational drug aliskiren failed to show superiority over full-dose treatment with the existing “gold standard” therapy angiotensin-converting enzyme (ACE) inhibitor enalapril.

St. Jude Medical Inc. announced expansion of its EnSite Precision cardiac mapping system limited market release in Europe.

A large randomized controlled trial of ischemic postconditioning in patients who had experienced ST-segment elevation myocardial infarction (STEMI) failed to show the procedure significantly reduces death from any cause or hospitalization for heart failure.

April 19, 2016 — Researchers have confirmed that certain heart rhythm medications, when given by paramedics to patients with out-of-hospital cardiac arrest who had failed electrical shock treatment, improved likelihood of patients surviving transport to the hospital.

Delayed or deferred stent implantation in patients showed no clinical benefit in patients experiencing the deadliest form of heart attack, ST-segment elevation myocardial infarction (STEMI), according to research presented at the American College of Cardiology’s 65th Annual Scientific Session (ACC.16).

St. Jude Medical Inc. announced the U.S. launch and first U.S. implants of the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D) with MultiPoint Pacing Technology.

Considering RFID to track healthcare inventory?

Healthcare reform is changing the way you provide care. With a focus on cost efficiency and quality, tracking utilization and efficient inventory management are big opportunities in your Cardiovascular Suite to help you manage costs and support patient safety initiatives. See how using the right tool for the right supply is key to demonstrating ROI.

To view the video from Cardinal Health, please complete the registration form below.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now